You searched for Humanized antibody - Page 6 of 44

News and Trends 6 Dec 2016

How is European Immuno-Oncology fighting Blood Cancer?

…also announced Phase I results for IPH4102, a humanized monoclonal antibody to treat cutaneous T-cell lymphomas (CTCL), a subtype of non-Hodgkin’s lymphoma. Argenx, in the Netherlands, has two antibody…

December 6, 2016 - 4 minutesmins - By Clara Rodríguez Fernández

News and Trends 30 Apr 2018

Record Series B Financing Supports Antibody Cancer Therapy

…of antibody-based therapies for cancer has recently been on the rise in European biotech. For example, late last year Argenx raised €195M to support the clinical development of its antibody…

April 30, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 4 Jun 2020

Update: Fifth US Antibody Patent Owned by UK Biotech Upheld in Regeneron Battle

Update (04/06/2020): After upholding four of Kymab’s patents addressing the production of antibody drugs earlier this year, the US Patent Trial and Appeal Board has rejected Regeneron’s attempt to invalidate…

June 4, 2020 - 4 minutesmins - By Anita Chakraverty

News and Trends 31 May 2017

German Biotech Enters the Clinic with Next-Generation Antibody for AML

Synimmune has hit the clinic with a first-in-human study of its Fc-optimized antibody FlySyn to treat patients with acute myeloid leukemia (AML). The German biotech Synimmune is developing next-generation anti-cancer…

May 31, 2017 - 2 minutesmins - By Melanie De Almeida

News and Trends 11 Oct 2016

UK Upstart to sign Huge Deal with Takeda in End Run around Antibody Therapies

…unabridged antibody counterparts, almost comparable to small peptides. Figure 1. A diagram of a whole antibody – Humabodies whittle these down to just the VH domain reflecting the antibody binding…

October 11, 2016 - 3 minutesmins - By Evelyn Warner

News and Trends 16 Jan 2025

Top biotech deals of December 2024

…and development (R&D) plans. Biotech deals by approach in December 2024 Biotechs continue antibody-drug conjugates R&D streak As usual, licensing deals for antibody-drug conjugates make the cut. American pharma Gilead…

January 16, 2025 - 9 minutesmins - By Roohi Mariam Peter

Interview 12 Feb 2018

MorphoSys’ CEO Tells Us What’s Next for Europe’s Antibody Expert

…those compounds,” he continued. MorphoSys’ first attempt at taking its own antibody to market will be with its blood cancer candidate, MOR208, a monoclonal antibody that targets CD19, which is…

February 12, 2018 - 8 minutesmins - By Alex Dale

novimmune shire hemophilia antibody roche

News and Trends 18 Jul 2017

Shire In-Licenses Swiss Antibody for Hemophilia A to Compete with Roche

Shire has bought exclusive worldwide rights to develop and commercialize a bispecific antibody from Novimmune that could improve the treatment of hemophilia A. Novimmune is a biotech from Geneva that…

July 18, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 27 Jul 2023

Epsilogen completes first clinical trial of IgE antibody to treat cancer

Epsilogen, a producer of immunoglobulin E (IgE) antibodies to treat cancer, has published the final phase I data from the first ever clinical trial of an IgE antibody therapeutic. The…

July 27, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 19 Feb 2018

Is Novartis’ Psoriasis Drug Going to Steal Humira’s Crown?

…million people and impacts quality of life due to its visibility. Cosentyx is a fully humanized monoclonal antibody that specifically inhibits IL-17a, a cytokine that is strongly implicated in psoriasis….

February 19, 2018 - 3 minutesmins - By Alex Dale

News and Trends 2 Nov 2016

Antibody Therapies are here to Revolutionize Dermatology

…royalties of up to a sweet €111.5M per antibody program. MorphoSys’ Ylanthia is the industry’s largest antibody Fab library Dermatology is an area with little innovation despite the big unmet…

November 2, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 8 Nov 2017

Phase I Results are in for Swedish Biotech’s Cancer Antibody

…also signed an agreement with MAB Discovery to support its antibody pipeline. MorphoSys has looked to combine its anti-cancer antibody, MOR208, with lenalidomide – a first-line drug for lymphoma. An…

November 8, 2017 - 3 minutesmins - By Alex Dale

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

How is European Immuno-Oncology fighting Blood Cancer?

Record Series B Financing Supports Antibody Cancer Therapy

Update: Fifth US Antibody Patent Owned by UK Biotech Upheld in Regeneron Battle

German Biotech Enters the Clinic with Next-Generation Antibody for AML

UK Upstart to sign Huge Deal with Takeda in End Run around Antibody Therapies

Top biotech deals of December 2024

MorphoSys’ CEO Tells Us What’s Next for Europe’s Antibody Expert

Shire In-Licenses Swiss Antibody for Hemophilia A to Compete with Roche

Epsilogen completes first clinical trial of IgE antibody to treat cancer

Is Novartis’ Psoriasis Drug Going to Steal Humira’s Crown?

Antibody Therapies are here to Revolutionize Dermatology

Phase I Results are in for Swedish Biotech’s Cancer Antibody

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!